NCT01847599 Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib Status TERMINATED Phase NA
NCT01837095 Dose Escalation of POL6326 in Combination With Eribulin in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1
NCT01814150 The Association Between Alpha 1 Acid Glycoprotein Level and Outcome Metastatic Cancer Treated With Docetaxel Status UNKNOWN Phase N/A
NCT01802970 Safety and Blood Immune Cell Study of Anakinra Plus Physician's Chemotherapy Choice in Metastatic Breast Cancer Patients Status COMPLETED Phase PHASE1
NCT01797120 Study of Fulvestrant +/- Everolimus in Post-Menopausal, Hormone-Receptor + Metastatic Breast Ca Resistant to AI Status COMPLETED Phase PHASE2
NCT01792050 Study of Chemotherapy in Combination With IDO Inhibitor in Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01785992 A Study of the Safety and Effectiveness of Irosustat When Added to an AI in ER+ve Locally Advanced or Metastatic Breast Cancer. Status COMPLETED Phase PHASE2
NCT01784120 A Phase II Trial of Doxorubicin and Genexol-PM in Patients With Advanced Breast Cancer Status UNKNOWN Phase PHASE2
NCT01773460 Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane Status TERMINATED Phase PHASE3
NCT01733628 Evaluation of Hypertension as a Predictor of Efficacy Bevacizumab in Metastatic Breast Cancer and Colorectal Cancer Status COMPLETED Phase N/A
NCT01730677 Lapatinib+Vinorelbine vs Vinorelbine HER2 Positive Metastatic Breast Cancer Progressed After Lapatinib/Trastuzumab Status UNKNOWN Phase PHASE2
NCT01715155 Management of Metastatic Breast Cancer in Clinical Practice - Retrospective Study Status COMPLETED Phase N/A
NCT01701050 Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index Status COMPLETED Phase N/A